Sugar Derivatives TRIZ Cases

Single-tube PCR uses fluorescent primers and Tm-based melting curves to detect 15 pathogens with higher throughput and no hardware changes.

Bioreductive markers use click chemistry to map hypoxic tumor cells for imaging and therapy where radiotherapy and chemotherapy face resistance.

Stool or plasma DNA methylation markers improve early gastric cancer detection with high specificity and sensitivity without invasive biopsy.

Slower β-glucuronidase-cleavable linkers improve ADC stability and solubility while limiting off-target microtubule inhibitor release.

Precipitating mRNA before membrane filtration removes aborted RNA and reagent impurities while preserving high integrity at large scale.

A 6′-substituted bridged nucleoside improves ssRNA binding and enzyme resistance while avoiding isomer separation in synthesis.

Haloalkyl-modified nucleobases enable safe, precise bioluminescent detection of DNA synthesis and cell proliferation without radioactivity.

CDA-resistant deoxy-cytidine and uridine derivatives target tumor proliferation while reducing off-target toxicity in cancer therapy.

Antibodies targeting HLA-DQ2.5 gliadin peptide complexes replace unstable low-affinity recombinant TCRs for celiac detection and therapy.

Methylated DNA markers in stool improve signal-to-noise and specificity for earlier pancreatic and colorectal cancer detection.

Hairpin initiators and bifunctional linkers cut mis-tagging and sequencing noise in DNA-encoded libraries while preserving reaction diversity.

An aged iodine oxidation solution selectively converts phosphite triesters while preserving phosphorothioate linkages in mixed P═O/P═S oligonucleotides.

Polymeric chromophore probes stay in solution to speed hybridization, cut washing, and enable in vivo, real-time nucleic acid detection.

Guide RNA directs Cas9 to cleave HSV-1 DNA, creating indels that suppress viral replication and help prevent latent reactivation.

Modified nucleotide analogs improve siRNA stability, cellular uptake, and silencing duration while reducing off-target gene effects.

A regulatable intron uses UPR-triggered splicing to suppress background expression and enable timed production of toxic proteins in eukaryotic cells.

A natural 192 bp HPS1 promoter deletion boosts rice disease resistance and enables marker-assisted breeding without transgenic complexity.

Activated phosphoramidite coupling speeds oligonucleotide condensation on solid supports despite steric hindrance and solvent swelling limits.

Acetal and thiocarbamate 3'-OH blocking groups improve sequencing accuracy by staying stable during incorporation yet removable under mild conditions.

A host crystal with crystallization-promoting molecules captures large, polar, and amphiphilic targets while speeding single-crystal preparation.

Short modified oligonucleotide fragments are ligated into complementary duplexes to improve siRNA purity and yield over long-chain synthesis.

Specific internucleoside linking groups improve antisense nuclease resistance while preserving tolerability and raising therapeutic index.

Modified cleavable nucleotides improve polymerase recognition and incorporation accuracy while enabling detectable sequencing signals.

4-guanidinocytidine modification helps mRNA reduce immune response while increasing in vivo protein expression for better therapeutic effect.

Multiwell plates with magnetic beads and electrochemically generated acid enable template-free DNA synthesis and high-fidelity assembly of larger genomes.

High-temperature ligation and denaturation-annealing cycles reduce non-target strands and improve long nucleotide synthesis purity and yield.

C-terminal deletion and targeted residue substitutions improve fucose binding, thermal stability, and E. coli expression yield.

A soluble protecting group enables scalable oligonucleotide synthesis with lower reagent use, reaction monitoring, and controlled base cleavage.

β-glucuronidase-cleavable ADC linkers improve stability and solubility while enabling selective drug release with lower toxicity.

A glucosyringic acid analog modulates sweet taste receptors to speed sweetness onset and reduce bitter, licorice, and lingering off-notes.

Controlled cooling, agitation, and seed crystals raise allulose crystallization yield while keeping crystal shape and size suitable for use.

Aldehyde-amine imine compounds mimic a natural nectar pigment while adding fluorescence, biodegradability, and amine detection.

Novel hexose derivatives raise melting temperature and limit denaturation, aggregation, and desiccation in biological materials.

Selective amidation capping of amino and hydroxyl groups cuts byproducts and improves crude purity and yield in chiral oligonucleotide synthesis.

ASGPR-binding degraders route extracellular immunoglobulins to hepatocytes for selective lysosomal clearance with lower dose and fewer side effects.

Ligand-linker oligonucleotide conjugates improve ASGPR-targeted delivery and serum protection for more specific gene silencing.

Amino acid and carbohydrate psilocin conjugates improve gut, cornea, and skin permeability to boost bioavailability and brain delivery.

Quaternary ammonium rifampicin derivatives improve oxidation and hydrolysis stability while retaining antibacterial activity against resistant strains.

A controlled ethanol ratio and seeded cooling raise D-psicose crystal yield and size while limiting residual ethanol taste and smell.

Enzyme-cleavable conjugates balance selective tumor drug release with stability, solubility, and lower off-target toxicity in cancer treatment.

High-affinity binding to ActRIIA and ActRIIB blocks activin signaling to stimulate muscle growth and reduce wasting.

Reconditioned anion exchange material and interchangeable cassettes enable serial 18F radiopharmaceutical batches with less cleaning, downtime, and exposure.

Blocking tau uptake through LRP1 and SorLA antagonists helps limit neuronal tau spread and neurofibrillary tangle formation.

Urine sediment methylation and mutation analysis helps monitor bladder cancer recurrence risk while reducing reliance on frequent cystoscopy.

ODC1 genotype-guided DFMO therapy targets polyamine biosynthesis to reduce relapse risk and treatment pain in high-risk neuroblastoma.

Fluorinated alkylumbelliferyl glucopyranosides boost fluorescence and heat stability, enabling faster, more accurate sterilization efficacy checks.

A bio-orthogonal cleaving agent detaches radionuclide labels from non-target biomolecules to speed renal clearance and improve tumor-to-blood ratios.

Tangential flow filtration with denaturing agents removes shortmers and enzyme reagents from synthesized mRNA without hazardous solvents.

Rigid-linker FRET nucleotides keep luminescent molecules separated to boost signal consistency and reduce optical filter needs in sequencing.

A self-immolative linker keeps ligand-drug conjugates stable in plasma, then triggers selective release at target cells to limit side effects.